WHO Gives Update As Ebola Cases Surge Past 1000 In DRC Congo

The Democratic Republic of the Congo (DRC) is currently grappling with a rapidly escalating and highly complex Ebola epidemic. Described by the World Health Organization (WHO) as a “catastrophic collision of disease and conflict,” the outbreak is spreading fiercely through the country’s highly volatile eastern provinces.

The crisis reached a tipping point when the WHO officially declared the epidemic a Public Health Emergency of International Concern (PHEIC), while the Africa CDC designated it a Public Health Emergency of Continental Security.

The Data: A Rapidly Evolving Crisis

The current outbreak is moving at an alarming pace. Within just weeks of the official declaration, health agencies have documented massive numbers that experts fear vastly underrepresent the true scale of the crisis due to limited testing access in remote areas.

Epidemic Indicator National Figures (Combined DRC & Uganda)
Confirmed Cases ~119
Suspected Cases Over 1,200
Estimated Total Deaths 264+ (including ~220 suspected deaths)
Prevalent Strain Bundibugyo ebolavirus (BDBV)

The epicenter is centered primarily within the Ituri Province (including Bunia, Rwampara, and Mongbwalu), but has quickly breached containment lines. Imported cases have now been confirmed in major population hubs, including Goma and Butembo in North Kivu, South Kivu, and across the international border into Kampala, Uganda.

Why Containment is Exceptionally Difficult

Unlike the more common Zaire strain that struck the region in previous years, this epidemic presents a unique and terrifying set of operational hurdles for global health workers:

1. Zero Approved Vaccines or Treatments

The current outbreak is fueled by the rare Bundibugyo strain. While the medical community successfully deployed highly effective vaccines (like Ervebo) and monoclonal antibody treatments to crush past Zaire-strain outbreaks, there is currently no licensed vaccine or specific treatment for the Bundibugyo virus. Doctors are restricted to offering supportive hydration and symptom management while urgently trying to fast-track experimental clinical trials.

2. Active Warfare and Militia Violence

The geographic hotspot sits directly in an active war zone where the DRC military is actively battling heavily armed rebel factions, including the Rwanda-backed M23 movement, CODECO militias, and the Allied Democratic Forces (ADF).

“We cannot build community trust or isolate the sick while bombs are falling,” warned WHO Director-General Tedros Adhanom Ghebreyesus.

Ongoing clashes have triggered mass civilian displacements, pushing thousands of potentially exposed contacts into tightly overcrowded, unhygienic internally displaced person (IDP) camps. Armed groups have also targeted local health clinics, making active contact tracing nearly impossible.

3. Deepening Humanitarian and Hunger Emergency

The biological threat is hitting a population that is already physically compromised. UN monitors indicate that nearly 10 million people across Ituri, North Kivu, South Kivu, and Tanganyika are facing acute, severe hunger. Malnourishment leaves the local population with weakened immune systems, making human bodies far more vulnerable to severe infections and accelerating mortality rates.

The International Response

With UNICEF triggering its highest Level 3 Corporate Emergency status and releasing millions in emergency funding, an international coalition is trying to establish active exit screenings at airports and border crossings to limit international spread.

Public health experts emphasize that until an immediate humanitarian ceasefire is achieved to allow medical teams safe passage into rebel-held territories, the Bundibugyo outbreak threatens to outpace the global response entirely.

WHO Report Unveils More Men Died Than Women During COVID-19 Pandemic

A new analysis from the World Health Organization (WHO) reveals that the true human cost of the COVID-19 pandemic is far higher than previously recorded. According to the World Health Statistics Report 2026, the pandemic was associated with 22.1 million excess deaths between 2020 and 2023—a figure more than triple the 7 million deaths officially reported.

The Gender Disparity in Mortality

The report highlights a significant gender gap in pandemic-related deaths. Data shows that men bore a disproportionate burden of the mortality rate, accounting for 57% of all excess deaths, while women accounted for 43%. This finding provides researchers with a deeper understanding of how the crisis affected different demographic groups across the globe.

Measuring the “True Cost”

To understand the full impact, the WHO utilized “excess mortality” as a metric. This measures the number of deaths above what is historically expected, capturing a range of factors beyond direct viral infections:

  • Direct Impact: Deaths caused specifically by COVID-19.

  • Indirect Impact: Deaths resulting from overwhelmed healthcare systems, delayed medical treatments for other conditions, economic instability, and social disruption.

The report suggests that for every one officially recorded COVID-19 death, there were approximately two additional uncounted deaths, largely due to limited testing and weak reporting systems in various regions.

Timeline of the Crisis

The global mortality surge reached its apex in 2021, during which an estimated 10.4 million people died above expected levels. This peak aligned with the rise of the Delta variant and a global shortage of critical medical resources, including hospital beds and oxygen supplies.

While excess mortality began to decline as the pandemic progressed, the effects remained lingering by 2023. Although the figure dropped to 3.3 million excess deaths that year, global mortality levels remained notably higher than pre-pandemic baselines.

A Call for Global Preparedness

The WHO emphasizes that these updated figures serve as a critical wake-up call for the international community. The report concludes that the devastating toll underscores an urgent need for:

  • Stronger health systems capable of absorbing sudden shocks.

  • Enhanced disease surveillance to ensure accurate data during crises.

  • Improved global preparedness to mitigate the impact of future health emergencies.

By revealing the hidden scale of the pandemic, the WHO aims to guide policymakers in building more resilient infrastructures to protect vulnerable populations in the years to come.

Beyond Daily Pills- WHO Backs New Long-Acting HIV Prevention Injection

The World Health Organization (WHO) has released groundbreaking new guidelines recommending the use of injectable lenacapavir (LEN) twice a year as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention. This recommendation marks a landmark policy action poised to significantly reshape the global HIV response.

Lenacapavir, recognized as the first twice-yearly injectable PrEP product, offers a highly effective and long-acting alternative to daily oral pills and other shorter-acting prevention methods. With just two doses per year, LEN represents a transformative step forward in protecting individuals at risk of HIV, particularly those who encounter difficulties with daily medication adherence, face significant stigma, or have limited access to consistent health care.

Speaking at the 13th International AIDS Society Conference (IAS 2025) on HIV Science in Kigali, Rwanda, where the guidelines were issued, WHO Director-General Dr. Tedros Adhanom Ghebreyesus emphasized the importance of this development. He stated that while an HIV vaccine remains elusive, lenacapavir stands as “the next best thing: a long-acting antiretroviral shown in trials to prevent almost all HIV infections among those at risk.”

Dr. Tedros further articulated WHO’s commitment:

“The launch of WHO’s new guidelines, alongside the FDA’s recent approval, marks a critical step forward in expanding access to this powerful tool. WHO is committed to working with countries and partners to ensure this innovation reaches communities as quickly and safely as possible.”

The issuance of these new guidelines comes at a critical juncture, as global HIV prevention efforts have shown signs of stagnation, with an alarming 1.3 million new HIV infections occurring in 2024. This impact is disproportionately felt among key and priority populations, including sex workers, men who have sex with men, transgender people, people who inject drugs, people in prisons, and children and adolescents. WHO’s recommendation on LEN signals a decisive move to expand and diversify HIV prevention strategies, providing individuals with more practical options to take control over their health with choices that better integrate into their daily lives.